🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Morning vs Bedtime Dosing and Nocturnal Blood Pressure Reduction jamanetwork.com/journals/jaman…

#Obesity is not just a comorbidity, it plays a key role in the development & progression of #HeartFailure Some 🔑 takeaways from #EJHF #HFA_ESC scientific statement: 📌Obesity alters myocardial energetics (FA oxidation, glucose & ketones) 📌Epicardial/visceral fat: linked to

CGM initiation has increased over time but remains <10% among insulin-treated older adults with T2D. Substantial racial, ethnic, and socioeconomic disparities were observed. via Diabetes Care, a research journal of the ADA 🌟 American Diabetes Association doi.org/10.2337/dca25-…

🔴Diagnosis and Management of #HFrEF & #HFpEF in 2025⤵️ 🚦Latest Paired Primary Care #hack Medscape PDF 🔹medscape.co.uk/viewarticle/di… 🔹medscape.co.uk/viewarticle/di… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter

#EHJIMP💪The Five Times Sit-to-Stand Test Predicts Achievable Exercise Intensity During Stress Echocardiography #Echofirst! Look at this article 👀: 🫀doi.org/10.1093/ehjimp…

59% of patients with type 2 diabetes in primary care clinics have MASLD, 7% have advanced fibrosis (transient elastography ≥ 10 kPa), and 1.9% have cirrhosis. onlinelibrary.wiley.com/doi/10.1111/jo…

🧪 New in AJPC: Exploring the link between SGLT2 inhibitors and atherosclerosis—what does the latest evidence reveal? 🔗 ow.ly/spL950WswCf #Cardiology #SGLT2 #Atherosclerosis #PreventiveCardiology #AJPC

🕒 Your heart has a clock, too. ⚠️Circadian rhythms in cardiovascular disease 💤 🕰️ Chronotherapy could be the secret weapon in personalized care. 🧠🫀 #CircadianRhythms #Cardiology #MedTwitter #StateOfTheArt #Review

🔴 2025 JCS/JHFS Guideline on Diagnosis and Treatment of Heart Failure⤵️ *New* 🔹onlinejcf.com/article/S1071-… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

🔴Aspirin in Primary Prevention: Looking for Those Who Enjoy It🩸⤵️ #2024Review #OpenAccess 🔹mdpi.com/2077-0383/13/1… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular

🫀 Does lowering heart rate improve outcomes in hypertension? 📊 Meta-analysis 74 trials Benefits only in In post-MI or HF target 65-70bpm: · ↓ Coronary heart disease: -16% · ↓ Heart failure: -9% · ↓ CV mortality: -14% · ↓ All-cause mortality: -13% academic.oup.com/eurheartj/arti…

nature.com/articles/s4156…

📊 The Obesity Care Cascade 🏥 Where does the breakdown occur in those who have BMI >30 and those who seek a doctor for advice? 🤔 🔻 The largest drop-off (83.7% relative disengagement) occurred between trying to lose weight and seeking professional help 💔 🔻 The second

Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: SUMMIT Trial ➡️ essentially…weight loss improves patient symptoms/functionality in HFpEF (‘obesity related HFpEF’) 😁 Prof Kamlesh Khunti GoggleDocs jacc.org/doi/10.1016/j.…

🩺 Does change in blood pressure variability over time matter? New UK Biobank study (n=36,251, median 13.9 yrs follow-up). 📈 ↑ SBP variability = ↑ risk of: · 🫀Cardiovascular disease · 🧪Chronic kidney disease · ⚰️All-cause mortality academic.oup.com/eurheartj/arti…

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT | JACC: Advances jacc.org/doi/10.1016/j.…

Pharmacological Therapy of HFrEF in 2025: Navigating New Advances and Old Unmet Needs in An Eternal Balance Between Progress and Perplexities The established four pillars of HFrEF treatment – β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor–

💥 Decision-making for older adults with advanced heart disease: a framework for balancing benefit versus futility 📄 pubmed.ncbi.nlm.nih.gov/40705035/

Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular disease academic.oup.com/eurheartj/arti…

New content online: Balancing weight and muscle loss in GLP1 receptor agonist therapy bit.ly/41il6iv